There are 3 companies that have evaluated the consistency of another variety
Last Update: 2019-05-13
Search more information of high quality chemicals, good prices and reliable suppliers, visit
Recently, the official website of Chongqing kangkeri Co., Ltd announced that its company has received the approval document for supplementary drug application (approval No.: 2019b02914) of glimepiride tablets (trade name: Li Yiping) approved and issued by the State Food and drug administration The drug specification of 1mg passed the quality and efficacy consistency evaluation of generic drugs Glimepiride tablet is suitable for type 2 diabetes mellitus, which can not control blood glucose adequately in diet, exercise therapy and weight loss Glimepiride tablets are not suitable for the treatment of type 1 diabetes (e.g diabetes patients with a history of ketoacidosis), diabetic ketoacidosis or diabetic precursor coma or coma According to the data of the International Diabetes Union, the number of diabetes patients in China reached 114.4 million (aged 20-79) in 2017, ranking first in the world It is predicted that the market of antidiabetic drugs will increase from RMB 512 billion in 2017 to RMB 173.9 billion in 2028, with a compound annual growth rate of 11.8% According to the drug intelligence data, three enterprises that have passed the consistency evaluation of glimepiride tablets so far involve two specifications For details, please see the following table: statement: This article is the content of yaozhi.com, and the opinions only represent the author, not the position of yaozhi.com You are welcome to exchange and supplement in the message area If you need to reprint, please be sure to indicate the author and source of the article.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to email@example.com
. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.